Legal Representation
Attorney
Kevin M. Bovard
USPTO Deadlines
Next Deadline
50 days remaining
NOA E-Mailed - SOU Required
Due Date
February 18, 2026
Extension Available
Until August 18, 2026
Application History
12 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 12, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 11, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 11, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 11, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 18, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 24, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 24, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 18, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 2, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 15, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 27, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 1, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceuticals for the treatment of rare genetic diseases; pharmaceuticals for the treatment of musculo-skeletal disorders; pharmaceuticals for the treatment of skeletal dysplasia; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of cells that are resistant to drugs; pharmaceuticals for the treatment and prevention of drug resistance; anti-cancer pharmaceuticals
Class 042
Research and development of drugs in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; scientific research for medical purposes in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; clinical research in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; scientific research and development of pharmaceuticals for the treatment of cancer, rare diseases, musculo-skeletal disorders, and skeletal dysplasia.
Class 044
providing medical information; providing medical information in the field of rare diseases, musculo-skeletal disorders, and skeletal dysplasia; Providing a web site featuring medical information; Providing a website featuring information in the field of rare diseases, musculo-skeletal disorders, and skeletal dysplasia; providing information in the field of pharmaceuticals; providing medical information in the field of oncology; providing a website featuring information in the field of the diagnosis and treatment of cancer.
Classification
International Classes
005
042
044